{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:27:52Z","timestamp":1793402872482,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031822","name":"CSIR - Institute of Himalayan Bioresource Technology","doi-asserted-by":"publisher","award":["5642"],"award-info":[{"award-number":["5642"]}],"id":[{"id":"10.13039\/100031822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP0201"],"award-info":[{"award-number":["MLP0201"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbrc.2025.151575","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:28:27Z","timestamp":1741238907000},"page":"151575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Determining the effect of natural compounds on mutations of pyrazinamidase in multidrug-resistant tuberculosis: Illuminating the dark tunnel"],"prefix":"10.1016","volume":"756","author":[{"given":"Rahul","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2101-9398","authenticated-orcid":false,"given":"Rituraj","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151575_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bbrc.2025.151575_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fped.2019.00350","article-title":"Immune response to Mycobacterium tuberculosis: a narrative review","volume":"7","author":"de Martino","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bbrc.2025.151575_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065202","article-title":"Tuberculosis: pathogenesis, current treatment regimens and new drug targets","volume":"24","author":"Alsayed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.151575_bib4","article-title":"Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) among children: where we stand now","volume":"15","author":"Chowdhury","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2025.151575_bib5","article-title":"Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: challenges and opportunities","volume":"7","author":"Chin","year":"2024","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.bbrc.2025.151575_bib6","first-page":"86","article-title":"New drugs and perspectives for new anti-tuberculosis regimens","author":"Tiberi","year":"2018","journal-title":"Rev. Port. Pneumol."},{"key":"10.1016\/j.bbrc.2025.151575_bib7","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global tuberculosis report 2020 \u2013 reflections on the global TB burden, treatment and prevention efforts","volume":"113","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.151575_bib8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.csbj.2020.05.009","article-title":"Determining the unbinding events and conserved motions associated with the pyrazinamide release due to resistance mutations of Mycobacterium tuberculosis pyrazinamidase","volume":"18","author":"Sheik Amamuddy","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbrc.2025.151575_bib9","first-page":"1","article-title":"The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD","volume":"11","author":"Sun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2025.151575_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1350699","article-title":"Pyrazinoic acid, the active form of the anti-tuberculosis drug pyrazinamide, and aromatic carboxylic acid analogs are protonophores","volume":"11","author":"Fontes","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2025.151575_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-4758-9","article-title":"Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China","volume":"20","author":"Xia","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbrc.2025.151575_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/femspd\/ftv037","article-title":"Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?","volume":"73","author":"den Hertog","year":"2015","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.bbrc.2025.151575_bib13","doi-asserted-by":"crossref","first-page":"19329","DOI":"10.1074\/jbc.M800694200","article-title":"Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis: an essential role for NAD in nonreplicating bacilli","volume":"283","author":"Boshoff","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2025.151575_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2958.2010.07099.x","article-title":"NAD+ auxotrophy is bacteriocidal for the tubercle bacilli","volume":"76","author":"Vilch\u00e8ze","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2025.151575_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2958.2003.03452.x","article-title":"A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host","volume":"48","author":"Purser","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2025.151575_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1574-6968.2004.tb09546.x","article-title":"Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice","volume":"234","author":"Kim","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bbrc.2025.151575_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbrc.2025.151575_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102013","article-title":"Pyrazinamide resistance and pncA mutations in drug resistant Mycobacterium tuberculosis clinical isolates from Myanmar","volume":"125","author":"Ei","year":"2020","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bbrc.2025.151575_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/IDR.S436161","article-title":"Prevalence, transmission and genetic diversity of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in hunan, China","volume":"17","author":"Liu","year":"2024","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.bbrc.2025.151575_bib20","article-title":"Resistance to pyrazinamide in Mycobacterium tuberculosis complex isolates from previously treated tuberculosis cases in Southwestern Oromia, Ethiopia","volume":"34","author":"Balay","year":"2024","journal-title":"J. Clin. Tuberc. Other Mycobact. Dis."},{"key":"10.1016\/j.bbrc.2025.151575_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5588\/ijtld.19.0314","article-title":"Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility","volume":"24","author":"Park","year":"2020","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.bbrc.2025.151575_bib22","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang","year":"2003","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.bbrc.2025.151575_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0023-2013","article-title":"Mechanisms of pyrazinamide action and resistance","volume":"2","author":"Zhang","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbrc.2025.151575_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tube.2017.12.002","article-title":"Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance","volume":"109","author":"Lohrasbi","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bbrc.2025.151575_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/14787210.2015.1021784","article-title":"Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria","volume":"13","author":"Stehr","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.bbrc.2025.151575_bib26","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/AAC.00204-15","article-title":"Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in mycobacterium tuberculosis clinical isolates","volume":"59","author":"Ramirez-Busby","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrc.2025.151575_bib27","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dkl363","article-title":"pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil","volume":"58","author":"Barco","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2025.151575_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-16-S2-S14","article-title":"Mechanistic analysis elucidating the relationship between Lys96 mutation in Mycobacterium tuberculosis pyrazinamidase enzyme and pyrazinamide susceptibility","volume":"16","author":"Vats","year":"2015","journal-title":"BMC Genom."},{"key":"10.1016\/j.bbrc.2025.151575_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.633365","article-title":"Insights into mutations induced conformational changes and rearrangement of Fe2+ ion in pncA gene of Mycobacterium tuberculosis to decipher the mechanism of resistance to pyrazinamide","volume":"8","author":"Nangraj","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2025.151575_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/med.20170","article-title":"Antitubercular potential of plants: a brief account of some important molecules","volume":"30","author":"Negi","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2025.151575_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015785","article-title":"Crystal structure of the pyrazinamidase of mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide","volume":"6","author":"Petrella","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.151575_bib32","series-title":"Dassault Systemes BIOVIA, Discovery Studio Modelling Environment, Release 4.5, Accelrys Softw","first-page":"98","author":"Studio","year":"2015"},{"key":"10.1016\/j.bbrc.2025.151575_bib33","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1021\/acs.jctc.7b00719","article-title":"Efficient geometry minimization and transition structure optimization using interpolated potential energy surfaces and iteratively updated hessians","volume":"13","author":"Zheng","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbrc.2025.151575_bib34","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1021\/acs.jchemed.9b00143","article-title":"PyMOL as an instructional tool to represent and manipulate the myoglobin\/hemoglobin protein system","volume":"96","author":"Lineback","year":"2019","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.bbrc.2025.151575_bib35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER - a CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.151575_bib36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.151575_bib37","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.151575_bib38","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.151575_bib39","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/jcc.21773","article-title":"Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5","volume":"32","author":"Abraham","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2025.151575_bib40","series-title":"Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton, XMGRACE","author":"Turner Pj","year":"2005"},{"key":"10.1016\/j.bbrc.2025.151575_bib41","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"G-mmpbsa -A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.151575_bib42","first-page":"39","author":"Izrailev","year":"1999","journal-title":"Steered Molec. Dynamic."},{"key":"10.1016\/j.bbrc.2025.151575_bib43","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1021\/acs.jcim.4c01174","article-title":"Conformations of KRAS4B affected by its partner binding and G12C mutation: insights from GaMD trajectory-image transformation-based deep learning","volume":"64","author":"Chen","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2025.151575_bib44","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules29102317","article-title":"Molecular mechanism of phosphorylation-mediated impacts on the conformation dynamics of GTP-bound KRAS probed by GaMD trajectory-based deep learning","volume":"29","author":"Chen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.151575_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.119101","article-title":"Screening and reckoning of potential therapeutic agents against DprE1 protein of Mycobacterium tuberculosis","volume":"358","author":"Singh","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bbrc.2025.151575_bib46","article-title":"Bioactives from medicinal herb against bedaquiline resistant tuberculosis: removing the dark clouds from the horizon","author":"Singh","year":"2023","journal-title":"Microb. Infect."},{"key":"10.1016\/j.bbrc.2025.151575_bib47","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1021\/acsomega.8b03258","article-title":"Effective estimation of ligand-binding affinity using biased sampling method","volume":"4","author":"Ngo","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2025.151575_bib48","first-page":"163","author":"Athanasiou","year":"2018","journal-title":"From Comput. Bedside: Comput. Chem. Contribut. FDA Approval"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2500289X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2500289X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:42:16Z","timestamp":1778636536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2500289X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"alternative-id":["S0006291X2500289X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151575","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining the effect of natural compounds on mutations of pyrazinamidase in multidrug-resistant tuberculosis: Illuminating the dark tunnel","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151575"}}